vs
Lottery.com Inc.（SEGG）与SELLAS Life Sciences Group, Inc.（SLS）财务数据对比。点击上方公司名可切换其他公司
Lottery.com Inc.的季度营收约是SELLAS Life Sciences Group, Inc.的1.7倍（$137.7K vs $79.0K），Lottery.com Inc.净利率更高（-3226.2% vs -12108.9%，领先8882.7%）
彩票办公室是获得澳大利亚北领地政府牌照的线上彩票运营商，支持澳大利亚和新西兰用户参与美国强力球、超级百万等全球顶级彩票的开奖投注。其母公司环球玩家网络私人有限公司自2003年起便持有合法运营牌照并接受监管。
SELLAS生命科学集团是一家处于后期临床阶段的生物制药企业，专注于开发针对未满足医疗需求的创新癌症免疫疗法，管线覆盖血液恶性肿瘤与实体瘤，核心候选产品适配急性髓系白血病等适应症，主要市场布局北美区域。
SEGG vs SLS — 直观对比
营收规模更大
SEGG
是对方的1.7倍
$79.0K
净利率更高
SEGG
高出8882.7%
-12108.9%
损益表 — Q3 FY2025 vs Q1 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $137.7K | $79.0K |
| 净利润 | $-4.4M | $-9.6M |
| 毛利率 | — | — |
| 营业利润率 | -3308.9% | -12208.9% |
| 净利率 | -3226.2% | -12108.9% |
| 营收同比 | -31.4% | — |
| 净利润同比 | 44.0% | 13.8% |
| 每股收益（稀释后） | $-1.19 | $-0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SEGGSLS
| Q3 25 | $137.7K | — | ||
| Q2 25 | $191.8K | — | ||
| Q1 25 | $223.8K | — | ||
| Q4 24 | $348.8K | — | ||
| Q3 24 | $200.7K | — | ||
| Q2 24 | $257.0K | — | ||
| Q1 24 | $259.3K | $79.0K | ||
| Q4 23 | $5.5M | — |
净利润SEGGSLS
| Q3 25 | $-4.4M | — | ||
| Q2 25 | $-3.9M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-7.9M | — | ||
| Q2 24 | $-5.9M | — | ||
| Q1 24 | $-5.6M | $-9.6M | ||
| Q4 23 | $-14.7M | — |
毛利率SEGGSLS
| Q3 25 | — | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 27.4% | — | ||
| Q4 24 | 69.8% | — | ||
| Q3 24 | 57.0% | — | ||
| Q2 24 | 82.3% | — | ||
| Q1 24 | 67.7% | — | ||
| Q4 23 | -0.1% | — |
营业利润率SEGGSLS
| Q3 25 | -3308.9% | — | ||
| Q2 25 | -2058.5% | — | ||
| Q1 25 | -1554.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1824.1% | — | ||
| Q2 24 | -2291.7% | — | ||
| Q1 24 | -2157.5% | -12208.9% | ||
| Q4 23 | -271.8% | — |
净利率SEGGSLS
| Q3 25 | -3226.2% | — | ||
| Q2 25 | -2022.3% | — | ||
| Q1 25 | -1477.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -3954.0% | — | ||
| Q2 24 | -2288.0% | — | ||
| Q1 24 | -2157.3% | -12108.9% | ||
| Q4 23 | -269.8% | — |
每股收益（稀释后）SEGGSLS
| Q3 25 | $-1.19 | — | ||
| Q2 25 | $-0.13 | — | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-7.86 | — | ||
| Q2 24 | $-1.12 | — | ||
| Q1 24 | $-1.40 | $-0.21 | ||
| Q4 23 | $-5.52 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $320.6K | $18.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $32.9M | $9.7M |
| 总资产 | $73.4M | $24.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资SEGGSLS
| Q3 25 | $320.6K | — | ||
| Q2 25 | $262.6K | — | ||
| Q1 25 | $468.7K | — | ||
| Q4 24 | $68.0K | — | ||
| Q3 24 | $60.5K | — | ||
| Q2 24 | $28.0K | — | ||
| Q1 24 | $84.0K | $18.4M | ||
| Q4 23 | $359.8K | — |
股东权益SEGGSLS
| Q3 25 | $32.9M | — | ||
| Q2 25 | $19.8M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | $20.5M | — | ||
| Q3 24 | $25.7M | — | ||
| Q2 24 | $30.7M | — | ||
| Q1 24 | $32.5M | $9.7M | ||
| Q4 23 | $34.5M | — |
总资产SEGGSLS
| Q3 25 | $73.4M | — | ||
| Q2 25 | $53.1M | — | ||
| Q1 25 | $53.4M | — | ||
| Q4 24 | $52.9M | — | ||
| Q3 24 | $58.4M | — | ||
| Q2 24 | $62.1M | — | ||
| Q1 24 | $63.1M | $24.4M | ||
| Q4 23 | $64.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.1M | $-10.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流SEGGSLS
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-3.2M | — | ||
| Q1 25 | $924.9K | — | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $2.4M | — | ||
| Q2 24 | $-368.1K | — | ||
| Q1 24 | $-1.1M | $-10.8M | ||
| Q4 23 | $-1.3M | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
